Tue Oct 01 09:08:45 UTC 2024: ## Institutional Investors Show Interest in R1 RCM Inc. as Company Reports Earnings Beat
**New York, NY – October 1st, 2024** – R1 RCM Inc. (NASDAQ:RCM), a leading provider of revenue cycle management solutions for healthcare providers, has seen increased interest from institutional investors, according to recent SEC filings. Dimensional Fund Advisors LP expanded its stake in the company by 4.5% during the second quarter, bringing its total holdings to $39.62 million.
Other notable investors include Capital International Investors, which increased its stake by 0.8%, and P2 Capital Partners LLC, which dramatically increased its position by 70,366.3%. Boston Partners and First Light Asset Management LLC also significantly increased their stakes in the company. Overall, hedge funds and institutional investors now own 61.10% of R1 RCM’s stock.
R1 RCM recently reported its earnings for the second quarter, exceeding analysts’ expectations with a profit of $0.02 per share. The company also reported revenue of $627.90 million, a 12% increase compared to the same period last year.
Despite the earnings beat, research analysts have mixed opinions on the company’s future prospects. Royal Bank of Canada maintains an “outperform” rating, while Stephens downgraded the company to “equal weight.” TD Cowen and Leerink Partners also lowered their ratings, while Truist Financial cut their target price. Overall, 13 analysts have assigned a “hold” rating, and 5 have assigned a “buy” rating, resulting in an average rating of “Hold” and a consensus target price of $15.41.
R1 RCM’s stock opened at $14.17 on Tuesday, with a market cap of $5.97 billion. The company’s financial metrics include a debt-to-equity ratio of 0.77, a quick ratio of 1.84, and a current ratio of 1.84.
While the company’s recent earnings beat has sparked interest from investors, analysts’ mixed ratings indicate uncertainty about R1 RCM’s future performance.
First Piper 